Progress report on new antiepileptic drugs: a summary of the Eleventh Eilat Conference (EILAT XI) - PubMed (original) (raw)
Review
Progress report on new antiepileptic drugs: a summary of the Eleventh Eilat Conference (EILAT XI)
Meir Bialer et al. Epilepsy Res. 2013 Jan.
Free article
Abstract
The Eleventh Eilat Conference on New Antiepileptic Drugs (AEDs)-EILAT XI, took place in Eilat, Israel from the 6th to 10th of May 2012. About 100 basic scientists, clinical pharmacologists and neurologists from 20 countries attended the conference, whose main themes included "Indications overlapping with epilepsy" and "Securing the successful development of an investigational antiepileptic drug in the current environment". Consistent with previous formats of this conference, a large part of the program was devoted to a review of AEDs in development, as well as updates on AEDs introduced since 1994. Like the EILAT X report, the current manuscript focuses only on the preclinical and clinical pharmacology of AEDs that are currently in development. These include brivaracetam, 2-deoxy-glucose, ganaxolone, ICA-105665, imepitoin, NAX 801-2, perampanel and other AMPA receptor antagonists, tonabersat, valnoctamide and its homologue sec-propylbutylacetamide (SPD), VX-765 and YK3089. Since the previous Eilat conference, retigabine (ezogabine) has been marketed and four newer AEDs in development (NAX 810-2, SPD, tonabersat and VX-765) are included in this manuscript.
Trial registration: ClinicalTrials.gov NCT01397968.
Copyright © 2012 Elsevier B.V. All rights reserved.
Similar articles
- Progress report on new antiepileptic drugs: a summary of the Tenth Eilat Conference (EILAT X).
Bialer M, Johannessen SI, Levy RH, Perucca E, Tomson T, White HS. Bialer M, et al. Epilepsy Res. 2010 Dec;92(2-3):89-124. doi: 10.1016/j.eplepsyres.2010.09.001. Epilepsy Res. 2010. PMID: 20970964 Review. - Progress report on new antiepileptic drugs: A summary of the Twelfth Eilat Conference (EILAT XII).
Bialer M, Johannessen SI, Levy RH, Perucca E, Tomson T, White HS. Bialer M, et al. Epilepsy Res. 2015 Mar;111:85-141. doi: 10.1016/j.eplepsyres.2015.01.001. Epub 2015 Jan 19. Epilepsy Res. 2015. PMID: 25769377 Review. - Progress report on new antiepileptic drugs: a summary of the Ninth Eilat Conference (EILAT IX).
Bialer M, Johannessen SI, Levy RH, Perucca E, Tomson T, White HS. Bialer M, et al. Epilepsy Res. 2009 Jan;83(1):1-43. doi: 10.1016/j.eplepsyres.2008.09.005. Epub 2008 Nov 12. Epilepsy Res. 2009. PMID: 19008076 - Progress report on new antiepileptic drugs: a summary of the Eigth Eilat Conference (EILAT VIII).
Bialer M, Johannessen SI, Kupferberg HJ, Levy RH, Perucca E, Tomson T. Bialer M, et al. Epilepsy Res. 2007 Jan;73(1):1-52. doi: 10.1016/j.eplepsyres.2006.10.008. Epub 2006 Dec 8. Epilepsy Res. 2007. PMID: 17158031 - Progress report on new antiepileptic drugs: A summary of the Thirteenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XIII).
Bialer M, Johannessen SI, Levy RH, Perucca E, Tomson T, White HS. Bialer M, et al. Epilepsia. 2017 Feb;58(2):181-221. doi: 10.1111/epi.13634. Epub 2017 Jan 23. Epilepsia. 2017. PMID: 28111749 Review.
Cited by
- Neural progenitor cell pyroptosis contributes to Zika virus-induced brain atrophy and represents a therapeutic target.
He Z, An S, Chen J, Zhang S, Tan C, Yu J, Ye H, Wu Y, Yuan J, Wu J, Zhu X, Li M. He Z, et al. Proc Natl Acad Sci U S A. 2020 Sep 22;117(38):23869-23878. doi: 10.1073/pnas.2007773117. Epub 2020 Sep 9. Proc Natl Acad Sci U S A. 2020. PMID: 32907937 Free PMC article. - A long way to go: caspase inhibitors in clinical use.
Dhani S, Zhao Y, Zhivotovsky B. Dhani S, et al. Cell Death Dis. 2021 Oct 15;12(10):949. doi: 10.1038/s41419-021-04240-3. Cell Death Dis. 2021. PMID: 34654807 Free PMC article. Review. - Imepitoin as novel treatment option for canine idiopathic epilepsy: pharmacokinetics, distribution, and metabolism in dogs.
Rundfeldt C, Gasparic A, Wlaź P. Rundfeldt C, et al. J Vet Pharmacol Ther. 2014 Oct;37(5):421-34. doi: 10.1111/jvp.12117. Epub 2014 Mar 10. J Vet Pharmacol Ther. 2014. PMID: 24611573 Free PMC article. Clinical Trial. - Altered gene expression profile in a mouse model of SCN8A encephalopathy.
Sprissler RS, Wagnon JL, Bunton-Stasyshyn RK, Meisler MH, Hammer MF. Sprissler RS, et al. Exp Neurol. 2017 Feb;288:134-141. doi: 10.1016/j.expneurol.2016.11.002. Epub 2016 Nov 9. Exp Neurol. 2017. PMID: 27836728 Free PMC article. - Tonic GABAA Receptors as Potential Target for the Treatment of Temporal Lobe Epilepsy.
Schipper S, Aalbers MW, Rijkers K, Swijsen A, Rigo JM, Hoogland G, Vles JS. Schipper S, et al. Mol Neurobiol. 2016 Oct;53(8):5252-65. doi: 10.1007/s12035-015-9423-8. Epub 2015 Sep 26. Mol Neurobiol. 2016. PMID: 26409480 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous